Document Detail


Interpretation of the Skin Cancer Quality of Life Score: A Validated Quality of Life Questionnaire for Non-Melanoma Skin Cancer.
MedLine Citation:
PMID:  25227398     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: Health-related quality of life (HRQoL) instruments are used increasingly. In order to assign clinical meaning to HRQoL scores, the interpretation of instruments is essential but lagging in dermatology. Objective: To establish a clinical interpretation of the Skin Cancer Quality of Life questionnaire (SCQoL), a newly validated HRQoL instrument for patients with non-melanoma skin cancer (NMSC), using an anchor-based method, and to test the responsiveness. Methods: Receiver-operating characteristic analysis was used to propose clinically meaningful cut-off scores for SCQoL including 101 patients with NMSC. Results: The following bands were established: score 0-3 corresponds to no impairment, 4-6 corresponds to mild impairment, 7-10 to moderate impairment and 11-27 to severe impairment of HRQoL. Testing the responsiveness shows a moderate effect size and significantly lower scores only for the domain emotion and the global item. Conclusion: Using proposed clinical cut-off scores for SCQoL may help clinicians in their decision-making, help monitoring clinical improvement and classify patients just as e.g. the Dermatology Life Quality Index can. © 2014 S. Karger AG, Basel.
Authors:
Gabrielle R Vinding; Solveig Esmann; Anne B Olesen; Lone B Hansen; Karl B Christensen; Gregor B E Jemec
Related Documents :
22031728 - Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal...
15946118 - Perceptions of positive meaning and vulnerability following breast cancer: predictors a...
3810198 - Concern about cancer in women undergoing elective gynaecological surgery.
11747058 - Psychometric properties of the impact of event scale amongst women at increased risk fo...
20943848 - Ca125 immune complexes in ovarian cancer patients with low ca125 concentrations.
23204698 - Most breast cancer screening trials have a flawed design.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-11
Journal Detail:
Title:  Dermatology (Basel, Switzerland)     Volume:  -     ISSN:  1421-9832     ISO Abbreviation:  Dermatology (Basel)     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203244     Medline TA:  Dermatology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  123-129     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hypertension: diagnosis, control status and its predictors in general population aged between 15 and...
Next Document:  Multiple Micronutrient Supplementation during Pregnancy and Lactation in Low-to-Middle-Income Develo...